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In this study, it was investigated how estrogens (17-b-estradiol, E2) affect the estrogen receptor (ER) expression
and gene regulation of male versus female human scalp hair follicles in vitro. Anagen VI follicles from
frontotemporal scalp skin were microdissected and organ-cultured for up to 9 d in the presence of E2 (1–100
nm). Immunohistochemistry was performed for ERb-expression, known to be predominant in human scalp hair
follicles, and for TGF-b2-expression (as negative key hair growth modulator), and E2-responsive genes in organ-
cultured human scalp hair follicles (48 h, 10 nM) were explored by cDNA microarray, using a commercial skin focus
chip (Memorec, Cologne, Germany). The distribution pattern of ERb and TGF-b2-immunoreactivity differed between
male and female hair follicles after 48 h culture. Of 1300 genes tested, several genes were regulated sex-dependent
differently. The study reveals substantial sex-dependent differences in the response of frontotemporal human
scalp hair follicles to E2. Recognition and systematic dissection of the E2-dependent gene regulation will be crucial
for the development of more effective, gender-tailored management strategies for female versus male pattern
balding.
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Estrogens (17-b-estradiol, E2) profoundly modulate hair
growth, acting largely as hair growth inhibitors (Kondo et al,
1990; Conrad and Paus, 2004; Nelson et al, 2003). We have
previously shown that E2 affects the hair shaft elongation
of human frontotemporal scalp hair follicles in vitro in a
differential, sex-dependent manner (Ohnemus et al, 2003;
Conrad et al, 2004). We have followed-up this initial
observation by investigating estrogen receptor (ER) expres-
sion and gene regulation of male versus female human
scalp hair follicles in vitro in order to further explore the
gender dependence of E2 effects on human hair follicles.
Results
The distribution pattern of ER type b (ER-b) immunoreactiv-
ity (IR) substantially differs between male (nuclear staining
predominant in the matrix keratinocytes) and female
(predominant ER-b staining in dermal papilla (DP) fibro-
blasts) hair follicles (Fig 1A–C).
Furthermore, E2 significantly increases the IR of ER-b in
DP fibroblasts of organ-cultured male human hair follicles
in situ (Fig 2), whereas no modulation of ER-b IR was
observed in E2-treated female scalp hair follicles (not
shown).
But comparing the steady-state levels for ER type a (ER-
a) and ER-b transcripts in male and female scalp hair
follicles by QT-PCR, no significant differences were de-
tected after E2 stimulation in vitro between the sexes (for
details, see Fig.S1). Although this remains to be confirmed
in more extensive future studies, it suggests that the sex-
dependent difference in ER-b-like IR detected by immuno-
histology is regulated on the post-transcriptional level.
Alternatively, even QT-PCR performed on total hair follicle
RNA may not be sensitive enough to detect these ER-b
expression differences that are prominent only in small,
defined follicle compartments (e.g., DP and matrix cells).
Of 1300 genes screened by a skin focus chip (micro-
array), more than 60 E2-responsive genes (o0.5-fold
suppressed or 41.5-fold stimulated) were detected in
human hair follicles. Several genes were modulated in
both sexes (e.g. downregulation of SPP1 (osteopontin);
Abbreviations: DP, dermal papilla; E2, 17-b-estradiol; ER, estrogen
receptor; ER-a, estrogen receptor type a; ER-b, estrogen receptor
type b; IR, immunoreactivity; MK, matrix keratinocytes; ORS, outer
root sheath; TGF-b2, transforming growth factor-b2
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upregulation of K6HF (cytokeratin type II)). In addition,
sex-dependent differences in E2-mediated gene regula-
tion were detected (for details see Fig 3 and Tables S1
and S2).
Hair follicle IR for transforming growth factor-b2 (TGF-b2)
also showed significant gender-dependent differences after
E2 treatment. In females, TGF-b2 IR increased significantly
in the lower outer root sheath, whereas it declined in male
hair follicles (Fig 4A–D).
Conclusions
These results support the concept that there are substantial
sex-dependent differences in the response of frontotem-
poral human scalp hair follicles to E2 (Conrad et al, 2004),
which likely are based on significant E2-dependent differ-
ences in gene regulation.
Although the differential gender-dependent gene regula-
tory effects of E2 on human hair follicles revealed in the
current pilot study all remain to be independently confirmed
by QT-PCR, and must therefore be interpreted with caution,
they already provide suggestive evidence that human scalp
Figure 2
17-b-estradiol (E2) significantly increases estrogen receptor type b
(ER-b)-like immunoreactivity in male frontotemporal scalp hair
follicles. Stimulation with E2 (10 nM) on organ-cultured male
frontotemporal scalp hair follicles increased the immunoreactivity of
ER-b 503 in the dermal papilla fibroblasts. Quantitative analysis using
Scion image (mean intensity), SEM, 0.01ppp0.05.
Figure 3
Sex-dependent differences in 17-b-es-
tradiol (E2)-responsive target genes in
frontotemporal human scalp hair folli-
cles. Suppression and stimulation of
genes in human scalp hair follicles using
a skin focus chip/microarray (white: fe-
male, black: male) after 48 h culture with
E2 (10 nM). Bone morphogenetic protein
7 (BMP7), cysteine-rich 61 (angiogenic
inducer), fibroblast growth factor receptor
2 (FGFR2), high endothelial venule protein
(HEVIN), nuclear receptor subfamily4,
groupA, member1 (NR4A1). For ratio list
of all genes see Tables S1 and S2.
Figure 1
Sex-dependent differences in estrogen receptor type b (ER-b)-like immunoreactivity in human frontotemporal scalp hair follicles. ER-b-like
immunoreactivity was found in (A) male microdissected frontotemporal scalp hair follicles predominantly in the matrix keratinocytes (MK), (B) in
female hair follicles immunoreactivity was predominantly found in the dermal papilla (DP) fibroblasts (ABC staining, substrat DAB
(diaminobenzadine) as chromogen, methylengreene-counterstaining, gray scale, and inverted, original magnification  100). (C) Quantitative
analysis of sex-dependent differences in ER-b-like immunoreactivity in the MK and DP was performed using Scion image (mean intensity), n¼36
hair follicles per group, SEM. 0.001ppp0.01.
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hair follicles respond to estrogen stimulation in an un-
expectedly sex-dependent manner.
In the context of the differential regulation of follicular
TGF-b2 expression by E2 observed here (Fig 4A–D), it is
intriguing to note that most recently a sex-specific E2 effect
toward TGF-b2-induced cataracts was observed in rats
(Chen et al, 2004). These two sets of data fit well to the
emerging concept that there is a much more generalized
differential control of growth factor expression and activities
by sex steroids (Klotz et al, 2000; Matsuda et al, 2001; Inui
et al, 2002) than widely appreciated in the skin research
community.
In addition, it has to be further investigated whether—just
like androgens (Itami et al, 1995; Jahoda and Reynolds,
1996; Inui et al, 2002)—E2 effects on the hair follicle are also
location dependent.
In summary, recognition and systematic dissection of
these differential E2 responses will be crucial for the
development of more effective, gender-tailored manage-
ment strategies for female versus male pattern balding.
Materials and Methods
Anagen VI follicles from frontotemporal scalp skin (obtained from
healthy males (n¼ 3) and females (n¼ 6) with informed consent
during routine facelift plastic surgery, all experiments were
performed according to the declaration of Helsinki Guidelines)
were microdissected and organ cultured (Philpott et al, 1990; Ito
et al, 2004) for up to 9 d in the presence of E2 (1–100 nM, n¼ 36
hair follicles per group, as in the non-treated control group).
Immunohistochemistry (Sahlin et al, 2000) was performed for the
predominant ER in the hair follicle, ER-b (Thornton et al, 2003),
using samples of all studied individuals, and both ER-a and ER-b
transcriptions were studied by QT-PCR (Taqman, Assays-on-
demand, Applied Biosystems, Foster City, CA (Hs00174860,
Hs00230957)) (Richards et al, 2003). E2-responsive genes in
organ-cultured human scalp hair follicles (using total RNA from
48 h-cultured hair follicles deriving from one female and one male
patient), comparing non-treated control versus 10 nM E2 treated
were explored by cDNA microarray using two commercial skin
focus chips (Memorec, Cologne, Germany) (Nakamura et al, 2003).
For QT-PCR and microarray analysis, microdissected and cultured
human hair follicles (15 hair follicles per group) were frozen in RNA
later after the culture period at 801C until further use. RNA
was isolated by using Qiagen RNeasy Mini Kit (Qiagen, Hilden,
Germany) according to the protocol provided by the manufacturer.
We also screened whether TGF-b2 IR in situ showed any sex-
dependent differences after E2 stimulation in vitro, given that TGF-
b2 is a key negative hair growth modulator (Hibino and Nishiyama,
2004).
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Figure 4
Transforming growth factor-b2 (TGF-b2)-like immunoreactivity expression pattern shows significant differences after 17-b-estradiol (E2)
treatment in the lower outer root sheath (ORS) in male and female hair follicles. (A, B) TGF-b2-like immunoreactivity increases significantly in
the lower ORS of (A) female scalp hair follicles and declines in the lower ORS of (B) male hair follicles after E2 treatment in vitro. Culture period 48 h
(TSA staining, label rhodamine, nuclear counterstaining 40,6-diamino-2-phenylindole (DAPI), gray scale and inverted, original magnification  250).
(C, D) Quantitative analysis of sex-dependent differences in TGF-b2-like immunoreactivity using Scion image (mean intensity), (C) female, (D) male,
E2-treated mean intensity was compared with the non-treated control, n¼ 36 hair follicles per group, SEM, p-value: 0.01oo0.05,
0.001oo0.01.
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Supplementary Material
The following material is available online for this article.
Figure S1 Comparison of the steady-state levels for estrogen
receptor-a and -b transcripts in male and female scalp hair follicles by
QT-PCR after 17b-estradiol(E2)-stimulation in vitro.
Table S1 Gene expression ratios of female human scalp hair follicles
after 17b-estradiol(E2)-stimulation in vitro
Table S2 Gene expression ratios of male human scalp hair follicles
after 17b-estradiol(E2)-stimulation in vitro
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